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Innate and adaptive immune cells in vertebrates 
are essential to coordinate and promote protec-
tive immunity. Primary and secondary lymphoid 
organs (SLOs) provide special microenviron-
ments allowing development and maturation of 
immune cells as well as induction and control of 
immune responses ( Junt et al., 2008; Mueller 
and Germain, 2009). These processes require 
dynamic interactions between diverse cell popu-
lations to trigger the appropriate signals to pro-
tect the organism against infections and tumors.
Notch signaling is an evolutionarily con-
served cell-to-cell signaling cascade, which in 
recent years was shown to be importantly in-
volved in lymphocyte development and adap-
tive immunity (Yuan et al., 2010; Radtke et al., 
2013). Vertebrates possess four Notch receptors 
(N1–N4) that are bound by five different trans-
membrane ligands of either the Jagged ( J1 and J2) 
or the -like family (DL1, DL3, and DL4). 
Conditional genetic loss-of-function (LOF) 
experiments in the mouse revealed that Notch 
signaling is essential for thymic T cell lineage 
commitment and maturation (Pui et al., 1999; 
Radtke et al., 1999), for development of splenic 
marginal zone (MZ) B cells (Saito et al., 2003; 
Hozumi et al., 2004) and Esam+ DCs (Skokos 
and Nussenzweig, 2007; Lewis et al., 2011), as 
well as for differentiation of follicular helper 
T cells (TFH) in the LN (Auderset et al., 2013).
The niches and identity of the ligand and/or 
ligand-expressing cells interacting with the Notch 
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Fibroblast-like cells of secondary lymphoid organs (SLO) are important for tissue architec-
ture. In addition, they regulate lymphocyte compartmentalization through the secretion of 
chemokines, and participate in the orchestration of appropriate cell–cell interactions 
required for adaptive immunity. Here, we provide data demonstrating the functional impor-
tance of SLO fibroblasts during Notch-mediated lineage specification and immune re-
sponse. Genetic ablation of the Notch ligand Delta-like (DL) identified splenic fibroblasts 
rather than hematopoietic or endothelial cells as niche cells, allowing Notch 2–driven 
differentiation of marginal zone B cells and of Esam+ dendritic cells. Moreover, conditional 
inactivation of DL4 in lymph node fibroblasts resulted in impaired follicular helper T cell 
differentiation and, consequently, in reduced numbers of germinal center B cells and ab-
sence of high-affinity antibodies. Our data demonstrate previously unknown roles for DL 
ligand-expressing fibroblasts in SLO niches as drivers of multiple Notch-mediated immune 
differentiation processes.
© 2014 Fasnacht et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it 
is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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in a complete loss of MZ B cells. We describe that the same 
DL1-expressing stromal cells are responsible for the differen-
tiation of Esam+ DCs. Moreover, we identified DL4-expressing, 
Ccl19-Cre+ fibroblasts (CD45CD31CD35+/Pdpn+) within 
LNs as important niche cells driving TFH cell differentiation 
after immunization with T cell–dependent antigens or para-
sites. Collectively, our data highlight the importance of Notch 
ligand expressing fibroblasts within SLO for the differentia-
tion of immune cells and T cell dependent antigen-driven 
immune responses.
RESULTS
MZ B cell development is dependent on DL-expressing 
fibroblastic stromal cells of the splenic follicle
It is well accepted that DL1-mediated Notch2 signaling is 
essential for MZ B cell development. However, how and 
through which DL1-expressing cell type this lineage decision 
is instructed is only partially understood. Reconstitution ex-
periments with WT hematopoietic precursors into irradiated 
DL1-deficient mice have indicated the importance of DL1 
expression in radiation-resistant splenic stromal cells rather 
than in radiation-sensitive hematopoietic cells (Sheng et al., 
2008; Tan et al., 2009). Expression analysis of DL1lacZ/+ mice 
identified DL1 expression mostly in BECs present in the red 
pulp of the spleen suggesting BECs as the likely niche cells for 
MZ B cell development. To test genetically whether DL1- 
expressing BECs are, indeed, responsible for MZ B cell differen-
tiation we crossed DL1lox/lox mice with PDGF-iCRE-ERT-ires-EGFP 
mice (Claxton et al., 2008), allowing tamoxifen-induced 
Cre-mediated inactivation of DL1 in CD31+ endothelial cells 
(hereafter, called DL1/PDGF). Immunohistological staining 
for EGFP confirmed transgenic Cre expression in BECs of the 
splenic red pulp, as well as in some endothelial cells lining the 
marginal sinus (Fig. 1 A and not depicted). Genetic inactivation of 
DL1 was verified by deletion PCR on CD45Ter119CD31+ 
cells sorted from splenic digests (Fig. 1 B). Surprisingly, rela-
tive and absolute numbers of MZ B cells were not signifi-
cantly altered in DL1/PDGF mice compared with control 
animals 2 mo after gene inactivation (Fig. 1, C and D). These 
genetic data suggest DL1-expressing BECs are not the essen-
tial niche cells for MZ B cell fate specification.
Because Delta ligands have been reported to be expressed 
on DCs (Skokos and Nussenzweig, 2007; Sekine et al., 2009), 
we also intercrossed DL1lox/lox mice with CD11c-Cre mice 
(DL1/CD11c) to formally exclude that some potentially radiation- 
resistant DC subset might function as niche cells for MZ 
B cell development. However, MZ B cell development was 
unperturbed in DL1/CD11c mice compared with controls 
(Fig. 1 E and not depicted). These inherently negative results, 
together with the previously reported data using chimeric 
mice (Sheng et al., 2008; Tan et al., 2009), excluded BECs and 
hematopoietic cells (including DCs) from being the critical 
DL1-expressing cells for MZ B cell development.
We therefore hypothesized that mesenchymal stromal 
cells of the spleen could be part of the DL1-expressing niche 
for MZB development. To test this possibility, we made use of 
receptor–expressing immune cells are largely unknown. In this 
regard, thymic T cell development is the notable exception, 
where DL4-expressing cortical thymic epithelial cells have been 
identified as niche cells providing Notch-1 signals to developing 
 T cells (Hozumi et al., 2008; Koch et al., 2008).
In the spleen, Notch has been implicated in the development 
of two important cell types, MZ B cells (Saito et al., 2003; 
Hozumi et al., 2004) and Esam+ DCs (Skokos and Nussenzweig, 
2007; Lewis et al., 2011). MZ B cells mediate the first line of 
defense against bloodborne pathogens by inducing T cell– 
independent antibody production. BM transplantation ex-
periments led to the suggestion that the DL1-expressing 
niche cells for MZ B cell development must be of nonhema-
topoietic origin (Sheng et al., 2008). As DL1 is highly ex-
pressed in blood endothelial cells (BECs) of the red pulp of 
the spleen, it was hypothesized that they could represent the 
niche cells driving this process (Tan et al., 2009).
DCs represent a subset of hematopoietic cells that are spe-
cialized in antigen presentation. Evidence that Notch signaling 
is regulating splenic DC development is derived from specific 
gene inactivation of RBP-J or Notch2 in DCs, which results 
in a strong reduction of the CD11c+CD8CD11b+Esam+ 
subset and a weaker reduction in Esam conventional DCs 
while leaving plasmacytoid DCs largely unaffected (Caton 
et al., 2007; Lewis et al., 2011). The Esam+ DC subset is involved 
in priming of CD4+ T cells upon antigen exposure. The ligands 
and ligand-expressing cells regulating DC development are 
currently unknown.
Notch signaling has also been implicated in differentiation 
and function of multiple subsets of T helper cells (Radtke 
et al., 2013). One recent addition is the role of Notch in T fol-
licular helper (TFH) cell differentiation (Auderset et al., 2013). 
This is a subset of CD4+ T cells, that differentiates after inter-
actions with DCs and subsequently migrates to the T/B-zone 
boundary within spleen and LN where they interact with 
Ag-specific B cells. TFH cells are critically involved in the 
formation of functional germinal centers (GC), and provide 
B cell help generating long-lived plasma cells (Crotty, 2011). 
We recently showed that T cell specific ablation of Notch1 
and Notch2 impairs differentiation of TFH cells in draining 
LNs of mice immunized with T cell–dependent antigens or 
parasites. Loss of TFH cells in Notch receptor mutant mice 
impaired GC formation, led to reduced numbers of GC B cells 
and consequently resulted in the absence of antigen-specific 
high affinity antibodies (Auderset et al., 2013). The ligands 
and niche cells responsible for TFH cell differentiation are cur-
rently unknown.
Here, we used systematic genetic LOF approaches to 
identify ligand-expressing niche cells in spleen and LNs, 
which provide the essential Notch signals for the develop-
ment of MZ B cells, Esam+ DCs, and TFH cells during T cell–
dependent immune responses. Using a recently developed 
transgenic model (Chai et al., 2013), we refine DL1 expres-
sion in the spleen on a subset of stromal CD45CD31Pdpn 
cells expressing a Ccl19-Cre transgene (Chai et al., 2013) and 
show that DL1 deletion in this stromal compartment results 
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CD45.2+ DL1lox/lox, DL1+/Ccl19 and DL1/Ccl19 mice were le-
thally irradiated and subsequently reconstituted with CD45.1+ 
WT BM cells. Reconstitution efficiency 12 wk after trans-
plantation was >85% (unpublished data). DL1+/Ccl19 and 
DL1/Ccl19 reverse BM chimeras revealed a dose-dependent 
reduction of MZ B cell numbers (Fig. 2, D and E). Collec-
tively, these results demonstrate that Ccl19-Cre–expressing 
splenic stromal cells are the essential DL1+ cells for Notch2 
driven MZ B cell development.
To characterize these splenic stromal niche cells, we 
intercrossed Ccl19-Cre with R26-EYFP and R26RmTmG  
reporter mice. In these mice, Cre-mediated excision of the 
lox-stop-lox cassette triggers EYFP or GFP expression only 
in Ccl19-expressing cells. Initially, R26-EYFP x Ccl19Cre 
mice were investigated and EYFP expression was predomi-
nantly found in a reticular pattern throughout the white pulp of 
the spleen, including Pdpn+ T zone FRCs (Fig. 3 A), as expected 
(Chai et al., 2013). Besides confirming Cre-mediated EYFP 
expression in T zone FRCs, immunohistological analysis of 
the spleen also identified EYFP expression in three follicular 
fibroblast populations: follicular DCs (FDCs), MAdCAM-1+ 
marginal reticular cells (MRCs) below the collagen IV+ 
subcapsular sinus, and reticular cells of the outer follicle, 
a BAC transgenic mouse model that drives expression of the 
Cre recombinase under the control of the Ccl19 promoter 
(Ccl19-Cre) that is known to be active in fibroblastic reticular 
cells (FRC) of the T zone (Onder et al., 2011; Chai et al., 2013). 
We intercrossed DL1lox/lox and DL4lox/lox mice with the BAC 
transgenic-cre driver line and generated DL1lox/lox Ccl19-Cre 
and DL4lox/lox Ccl19-Cre, hereafter called DL1/Ccl19 and 
DL4/Ccl19, respectively. Littermates lacking the Cre transgene 
were used as negative controls.
Flow cytometric analysis of splenic B cells derived from 
DL1/Ccl19 mice revealed a complete loss of MZ B cells, 
whereas inactivation of only one DL1 allele resulted in an 
50% reduction in relative and absolute MZ B cell numbers 
(Fig. 2, A and B). As expected, inactivation of DL4 in splenic 
stromal cells using DL4/Ccl19 mice had no effect on MZ 
B cell frequencies (not shown). These mice were analyzed 
as negative control to ensure that Ccl19-Cre expression does 
not perturb MZ B cell development. Immunohistological 
analysis of spleen sections confirmed loss of IgM+ IgD MZ 
B cells localizing just adjacent to the laminin+ marginal sinus 
in DL1/Ccl19 but not in control animals (Fig. 2 C).
To exclude a possible contribution of hematopoietic cells 
that may express Ccl19-Cre, we generated reverse chimeras. 
Figure . Inactivation of DL in PDGF+ 
BECs or CDc+ DCs does not perturb MZ 
B cell development. (A) Spleen sections of 
control (DL1lox/lox) and induced DL1PDGFiCreERT 
mice were stained for Collagen IV and GFP. 
Collagen IV stains basement membranes, most 
notably around blood vessels and in the mar-
ginal sinus. GFP is expressed bicistronically by 
the PDGF-promoter transgene construct. 
The dashed boxes are represented as a higher 
magnification on the right or below. B, B cell 
follicle; T, T cell zone; CA, central arteriole; MS, 
marginal sinus. Arrows indicate BECs and 
arrowheads the marginal sinus. (B) DL1 dele-
tion PCR on sorted CD45Ter119CD31+ en-
dothelial cells from spleens of control and 
tamoxifen-injected DL1/PDGF mice. (C) Rep-
resentative flow cytometry profile of MZ  
B cells (gated as CD21hiCD23int), pregated on 
B220+IgMhi cells, in spleens of control and 
tamoxifen-injected DL1/PDGF mice. (D) Bar 
diagrams show relative (left) and absolute cell 
number (right) of MZ B cells (MZB) in spleens 
of control and TAM-injected DL1/PDGF mice 
(means ± SD of 4–5 animals per group). One 
of two representative experiments is shown. 
(E) Bar diagrams show relative (left) and abso-
lute number (right) of splenic MZ B cells of 
control and DL1/CD11c mice (means ± SD of 
4–5 animals per group).
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referred here as B zone reticular cells (BRC; Fig. 3 A and 
not depicted).
To characterize the various splenic stromal cell popula-
tions, an isolation and gating strategy was established that 
allows the identification of three stromal cell subsets by flow 
cytometry: Pdpn+CD31 FRC, PdpnCD31+ BECs, and 
PdpnCD31 cells (double negative; DN). The gating on 
GFP+ cells in Ccl19-Cre reporter mice also allows the exclu-
sion of most red pulp fibroblasts. Ccl-19 Cre-triggered GFP 
expression in another comparable R26RmTmG reporter strain 
was found in a small subset of splenic stromal cells, with the 
vast majority of GFP+ cells belonging to T zone FRC and 
DN cells with the former population being markedly en-
riched over the nondeleted Tomato-expressing cells (Fig. 3 B; 
Chai et al., 2013). DN cells are likely to include all three fol-
licular fibroblast subsets (FDCs, MRCs, and BRCs), in addi-
tion to most red pulp fibroblasts. Importantly, BECs showed 
hardly any deletion, which is consistent with histological 
findings. No GFP expression was observed in hematopoietic 
cells, including DCs (unpublished data). Comparable results 
were obtained using the previously used reporter strain, 
R26EYFP (unpublished data). Ccl19-cre x R26RmTmG were 
also crossed onto the DL1lox/lox background to investigate 
DL1 gene deletion in the GFP+ spleen stroma subsets. Five 
clearly detectable stromal cell populations were sorted 
based on Tomato (Ccl19-Cre inactive) or GFP (Ccl19-Cre 
active) expression with DL1 deletion being confined to a 
subpopulation of GFP+ cells of the FRC and DN type 
(Fig. 3 C). Although only a partial DL1 deletion could be 
detected in GFP+ cells, a complete loss of MZ B cells was 
observed in DL1/Ccl19 mice (Fig. 2 A). These results sug-
gest that the Rosa gene locus is more accessible to Cre-
mediated deletion compared with the DL1 locus and/or 
that DL1 is only expressed in a subset of GFP+ FRC or 
DN cells.
Next, we assessed DL1 expression in various stromal sub-
sets to further characterize the niche cell. As DL1 protein ex-
pression could not be reproducibly detected on the surface 
of isolated stromal and hematopoietic cells, these cells were 
sorted from digested spleens of R26RmTmG x Ccl19-Cre mice 
and analyzed for DL1 transcripts by qRT-PCR. These experi-
ments revealed a strong enrichment of DL1 transcripts in 
GFP+ DN cells relative to Tomato+ DN cells (Fig. 3 D) con-
sistent with the notion that GFP identifies a DN fibroblast 
subset largely restricted to the white pulp cord, whereas To-
mato+ DN cells are likely to be enriched in red pulp fibro-
blasts. FRC, BECs, and meshed splenocytes showed much 
lower DL1 transcript levels. Comparable DL1 expression was 
observed with cells sorted from the spleen of R26-EYFP x 
Ccl19-Cre reporter mice (unpublished data). In contrast, in 
both mouse strains DL4 expression was predominantly con-
fined to the Ccl19-Cre FRC subset, whereas both Tomato+ 
and GFP+ FRC subsets expressed Pdpn transcripts (unpub-
lished data).
DL1 expression and inactivation was further investigated 
by immunohistochemistry on spleen sections derived from 
Figure 2. DL-expressing Ccl9-Cre+ splenic stromal cells are 
the essential niche cells for MZ B cell differentiation. (A) Repre-
sentative FACS profile displaying the frequency of splenic MZ B cells 
(gated as CD21hiCD23int) among B220+IgMhi cells in control, DL1+/Ccl19, 
and DL1/Ccl19 mice. (B) Bar diagrams show relative (left) and  
absolute numbers (right) of splenic MZ B cells (means ± SD of 5–6 
animals per group). (C) Spleen sections of control and DL1/Ccl19 mice 
were stained for IgM, IgD, and Laminin, as indicated. MS, marginal 
sinus (laminin+); FB, follicular B cells (IgM+D+); MZB, MZ B cells 
(IgM+D). (D) Representative FACS profiles displaying the frequency  
of splenic MZ B cells (CD21hiCD23int) among B220+IgMhi cells in  
control, DL1+/Ccl19 and DL1/Ccl19 reverse BM chimeras. (E) Bar dia-
grams show relative (left) and absolute numbers (right) of splenic  
MZ B cells in the reverse BM chimeras (means ± SD of 6–7 animals  
per group). **, P < 0.01; ***, P < 0.001. Unpaired Student’s t test was 
used to determine significance. Results are a composite of three  
independent experiments.
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DL-expressing stromal cells are required  
for development of splenic Esam+ DCs
DC-specific genetic LOF studies for RBP-J and Notch2 have 
revealed important functions of canonical Notch signaling 
for the development and homeostasis of specific subsets 
of splenic DCs. RBP-J is essential for the generation of 
CD8CD11b+Esam+ DCs, whereas Notch2 receptor signaling 
was implicated in the generation of all cDC types, including 
CD8, CD8+ and CD11b+ DC subsets (Caton et al., 2007; 
control and DL1/Ccl19 mice (Fig. 3 E). Histologically, DL1 
expression was found in several desminhigh cell types, includ-
ing MRCs, BRCs surrounding the desminlow CD35+ FDC 
cluster, and Pdpn+ FRC in the outer but not central T zone 
(Fig. 3 E). Surprisingly, DL1 expression was not detectable 
within the MZ or on red pulp vessels. Given that MRC and 
BRC of the spleen lack Pdpn and CD31 expression, they 
should be comprised in the DL1-transcript expressing DN 
cells identified by flow cytometry (Fig. 3, B–E).
Figure . Characterization of Ccl9-Cre 
activity and DL expression in stromal 
cells of the spleen. (A) Spleen sections of 
R26-EYFP (control) and R26-EYFPCcl19 mice 
stained for EYFP and collagen IV expression. 
EYFP staining is indicative for Cre recombi-
nase activity through the deletion of the lox-
stop-lox cassette in the R26 gene locus. 
Collagen IV highlights the basement mem-
brane of blood vessels and the marginal sinus. 
The dashed box is represented as a higher 
magnification on the right side. B, B cell fol-
licle; T, T cell zone. Arrow head pointing to 
EYFP reticular cells. FDCs; MRC, marginal  
fibroblastic reticular cells; BRCs; FRC, T zone 
fibroblastic reticular cells; CA, central arteriole. 
(B) Representative FACS profile of Tomato+ 
(Ccl19-Cre) and GFP+(Ccl19-Cre+) splenic stro-
mal cells isolated from mTmG/+Ccl19 reporter 
mice gated on AquaTer119CD45CD35 
cells and further analyzed for the expression 
of podoplanin (Pdpn, gp38+) and CD31. GFP+ 
cells represent the fraction of cells that ex-
press Ccl19-Cre. Percentages indicate the 
mean frequency among CD35 stromal cells 
(n = 5). (C and D) Cell populations from  
digested spleens of three individual  
mTmG/+Ccl19 mice were sorted as indicated in B, 
pooled, and assessed by semiquantitative PCR 
for the deleted () versus undeleted (loxP) 
DL1 gene (C) and by qRT-PCR for relative 
mRNA expression levels (D). The numbers in D 
indicate the fold enrichment relative to total 
WT splenocytes. Bars in D represent data from 
triplicate PCR reactions normalized to the 
HPRT housekeeping gene of pooled sorted 
stromal cells from 3 individual mice for the 
indicated reporter line. (E) Splenic sections of 
DL1lox/lox and DL1/Ccl19 mice were stained for 
DL1 (top), Pdpn, and desmin (bottom) as indi-
cated. Arrows point to different sites of DL1 
expression and stars denote examples of 
background staining (in form of larger dots) 
due to endogenous horseradish peroxidase 
activity. The dashed boxes are represented as 
a higher magnifications shown below the 
images. Experiments shown in A, B, and E are 
representative of two to five experiments with 
at least three different mice per group.
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DL1-induced DCs appeared not to depend on ligand dosage 
(Fig. 4, A–D). As expected, deletion of DL4 in Ccl19-Cre+ 
cells did not lead to significant changes in any of the DC sub-
sets analyzed, thereby demonstrating that only DL1 is essen-
tial for DC development (unpublished data). To exclude the 
possibility that splenic DC development is perturbed due to 
inappropriate inactivation of DL1 in a small subset of hemato-
poietic cells, reverse chimeras (WT→DL1/Ccl19, WT→
DL1+/Ccl19, and WT→DL1lox/lox) were generated and ana-
lyzed 12 wk after transplantation. The results of the reverse 
chimeras (unpublished data) confirmed and were consistent 
with the observations in the DL1/Ccl19 mutant animals, in-
dicating that loss of DL1 in stromal cells of the spleen is caus-
ative for the reduction of specific splenic DC subsets.
Esam+ DCs have been shown to be critical for priming 
of CD4+ T cells (Lewis et al., 2011). To test whether CD4 
Lewis et al., 2011). The Notch ligand responsible for direct-
ing splenic DC development is currently unknown. Because 
Esam+ DCs have been shown to be Notch2 dependent (Lewis 
et al., 2011), similar to MZ B cells, and to localize close to the 
splenic MZ (Caton et al., 2007), we hypothesized that both 
cell lineages might be specified by the same DL1-expressing 
stromal cells. To test this hypothesis, we analyzed the splenic 
DC compartment of DL1/Ccl19 compared with control ani-
mals. Loss of DL1 resulted in a marked decrease in relative 
and absolute numbers of CD11c+ DCs (Fig. 4, A and B). 
CD8Esam+ DCs are the most affected DC type but also 
splenic CD8+ and CD11b+ DC subsets showed lower overall 
percentages and absolute cell numbers in DL1/Ccl19 com-
pared with control mice (Fig. 4, C and D). In contrast to MZ 
B cell development, where loss of one DL1 allele resulted in 
a 50% reduction of MZ B cell numbers, the development of 
Figure 4. DL-expressing Ccl9+ splenic stromal cells regulate Notch-mediated differentiation of Esam+ DCs. (A) Representative FACS profile 
of splenic DCs (gated as CD11c+B220) of control, DL1+/Ccl19 and DL1/Ccl19 mice. (B) Bar diagrams show relative (left) and absolute numbers (right) of 
total splenic DCs (means of 4–5 mice per group, of two independent experiments). (C) Representative FACS profiles of Esam expression on total splenic 
CD11c+ DCs (top) and the different DC subsets (bottom), classified with CD8 and CD11b expression. Percentages represent mean ± SD of 5 animals per 
group of two independent experiments. (D) Bar diagrams show relative (top) and absolute numbers (bottom) of Esam+, CD11b+, and CD8+ DCs from 
spleens of control, DL1+/Ccl19 and DL1/Ccl19 mice (mean ± SD of 4–5 animals per group of two independent). (E) In vivo priming of CD4+ T cells in ab-
sence of Esam+ DCs. OT-II CD4+ T cells were purified, labeled with CFSE, and injected i.v. into control and DL1/Ccl19 mice that were subsequently immu-
nized with OVA and LPS as adjuvant. 3 d later, splenic cells were analyzed for the proliferation of the CFSE-labeled OT-II T cells. Representative data of one 
experiment are depicted and percentages of each cell division are shown as mean ± SD of two independent experiments with at least three animals per 
group. *, P < 0.05; **, P < 0.01. Unpaired Student’s t test was used to determine significance.
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DC subsets, we now explored whether such a mechanism 
could be conserved between different SLO. Therefore, we in-
vestigated if Ccl19-Cre+ LN stromal cells could be the ligand-
expressing niche cells that influence TFH differentiation. To 
investigate whether LN stromal cells might play a role in me-
diating Notch signals, Notch ligand mRNA expression was 
assessed on sorted stromal subpopulations based on CD31 
and Pdpn expression before, and two and five days after NP-
CGG immunization. Because DL1 and DL4 mRNA expres-
sion was up-regulated in Pdpn+ and in CD31+ cells after 
immunization (unpublished data), we focused our analysis 
on using DL1 and DL4 mutant animals that were crossed to 
Ccl19-Cre mice. DL1/Ccl19 and DL4/Ccl19 were analyzed 
14 d after NP-CGG immunization. Although Ccl19-Cre-
mediated inactivation of DL1 did not affect TFH cells, GC B cells 
or the production of NP-specific antibodies, DL4/Ccl19 mice 
exhibited a severe reduction in CD4+CXCR5+PD1+ TFH 
cells and concomitantly in GC B cells (Fig. 5, A and B). Both 
total and high affinity NP-specific antibodies were also drasti-
cally reduced in sera of DL4/Ccl19 but not DL1/Ccl19 or 
control animals (Fig. 5 C). Interestingly, reduction in TFH and GC 
B cells was similar in DL1/DL4/Ccl19 and DL4/Ccl19 mice 
indicating that DL1 cannot compensate for DL4 deficiency 
(Fig. 5, A–C). Immunization of the same DL mutant and control 
animals with S. mansoni eggs as second independent model 
confirmed the important role of DL4-expressing LN stromal 
cells as inducers of TFH and GC B cell differentiation, and of 
high affinity antibody responses following immunization with 
T-dependent antigens (Fig. 5, D–F).
To further characterize these Ccl19-Cre+ LN stromal 
niche cells we analyzed R26-EYFP Ccl19Cre reporter mice 
5 d after NP-CGG immunization. Immunohistological analy-
sis for the expression of EYFP was combined with the FDC 
marker CD35 and Pdpn, which is predominantly expressed on 
T zone FRCs but also on activated FDCs. Cre-mediated activ-
ity was observed in three fibroblast populations: CD35+Pdpn+ 
FDCs and CD35Pdpn+ cells with the latter comprising T zone 
FRCs, MAdCAM-1+ MRCs and some BRCs (Fig. 6 A; 
not depicted).
To further study DL4-expressing stromal cells, an im-
proved isolation protocol was established allowing not only 
the better isolation and identification of FRC, lymphatic en-
dothelial cells (LECs) and BECs, as described previously 
(Link et al., 2007), but also of CD35+Pdpn+ FDC. The find-
ing that the isolated FDC express high levels of both CD35 
and CD157 (BP3; Fig. 6 B, C) and were virtually absent in 
B cell deficient mice (unpublished data) suggested that we 
had successfully isolated and stained FDC from LN of WT 
mice. Flow cytometric analysis of stromal cells from LN of 
control and DL4/Ccl19 mice largely confirms the immuno-
histochemical analysis as it reveals that activated FDC (CD35+ 
CD31Pdpn+) shows the highest surface DL4 expression, 
which is abolished by Ccl19-Cre–mediated deletion, fol-
lowed by FRC (CD35-CD31Pdpn+) and to a lesser extent 
LEC (CD35CD31+Pdpn+; Fig. 6 B). While transcripts for 
DL4 were observed to be enriched in several stromal cell 
T cell priming is affected in DL1 mutant animals, ovalbumin-
specific OT-II CD4+ T cells were transferred into DL1/Ccl19 
or control mice, and subsequently immunized with OVA 
and LPS as adjuvant. Although OT-II CD4+ T cells were 
primed by wild-type DCs and therefore proliferated, CD4+ 
T cell priming in DL1/Ccl19 mice was strongly reduced cor-
relating with the severe reduction of Esam+ DCs and other 
DC subtypes (Fig. 4 E). Collectively, these data identify DL1 
as the ligand responsible for DC development in the spleen, 
most notably for Esam+ DCs in the MZ. Moreover, they re-
inforce the importance of Ccl19-cre+ DL1-expressing fibro-
blasts in instructing Notch-2 dependent development not 
only of MZ B cells but also of splenic DC.
DL4-expressing stromal cells of the LN are important niche 
cells for T follicular helper cell and GC B cell differentiation
We recently reported that Notch signaling regulates follicu-
lar T helper cell (TFH) differentiation (Auderset et al., 2013). 
T cell–specific gene ablation of Notch1 and Notch2 impaired 
differentiation of TFH cells in draining LNs of mice immu-
nized with T cell–dependent antigens and parasites. Impaired 
TFH cell differentiation correlated with deficient GC develop-
ment and absence of high-affinity antibodies (Auderset et al., 
2013). The ligands and ligand-expressing cells involved in this 
process are currently unknown. To identify the hematopoietic-
specific ligands that may trigger Notch-induced TFH cell 
differentiation, we made use of Mx-Cre mice and gener-
ated BM chimeras transplanting CD45.2+ BM cells from poly 
I-C–induced DL1/Mx, DL4/Mx, DL1/DL4/Mx, J1/Mx, 
J2/Mx, and J1/J2/Mx mice into lethally irradiated CD45.1+ 
wild-type mice. 12 wk after transplantation reconstitution 
efficiency for all BM chimeras was >90% (unpublished data). 
The different chimeric mutant and control animal cohorts 
were then immunized with NP-CGG in alum and analyzed 
14 d after immunization for the presence of PD1+CXCR5+ 
TFH, B220+GL7+CD95+ GC B cells and for high affinity 
NP-specific antibodies. Surprisingly, TFH cells, GC B cells and 
high-affinity antibodies developed normally in the various 
BM chimeras tested (unpublished data). To exclude the pos-
sibility that these inherently negative results are simply a con-
sequence of the chosen antigen, we repeated the experiments 
using Schistosoma mansoni eggs as a second independent model 
of immunization. S. mansoni eggs induce a stronger Th2 im-
mune response and TFH cell differentiation. However the results 
of this immunization protocol were similar to and in agreement 
with the NP-CGG model. TFH cells, GC B cells, S. mansoni 
soluble egg antigens (SEA)-specific antibodies were compa-
rable between control and DL mutant BM chimeras (unpub-
lished data). Inefficient inactivation of DL1 and DL4 or 
insufficient reconstitution of the different BM chimeras were 
excluded as possible reasons for these negative results (un-
published data). Collectively, these data strongly suggest that 
expression of Notch ligands on hematopoietic cells is dispens-
able for the generation of TFH cells.
Having shown the importance of DL1-expressing stromal 
cells in the spleen for the specification of MZ B cells and certain 
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To further define DL4-expressing cells within activated 
LN, immunofluorescence microscopy was performed. Strong 
DL4 protein expression was observed in several cell types 
within B cell follicles, namely CD35+ FDC and desminhigh 
MRC and BRC which all also express Pdpn (not shown). 
types relative to the total LN fraction, the almost complete 
Ccl19-Cre–mediated loss of DL4 transcripts and of the 
DL4 gene was only seen in activated FDC and FRC (Fig. 6, 
D and E), consistent with the results obtained by surface protein 
staining (Fig. 6 B).
Figure 5. DL4 expression on Ccl9+ LN fibroblasts is required for TFH and GC differentiation. (A) Representative FACS profiles of CD4+CXCR5+PD1+ 
TFH cells (top) and GL7+CD95+ GC B cells (bottom) from control, DL1/Ccl19, DL4/Ccl19, and DL1/DL4/Ccl19 mice 14 d after immunization with NP-CGG. 
Percentages in gates represent the frequency of TFH cells within CD4+ T cells and GC B cells within B220+ B cells, respectively. (B) Bar diagrams show rela-
tive (top) and absolute cell numbers (bottom) of TFH and GC cells in LNs of mice immunized 14 d earlier with NP-CGG (mean ± SD of 4–5 animals per 
group). (C) Total (NP23-binding) and high-affinity (NP4-binding) NP-specific IgG1 antibody levels were measured by ELISA in the sera of control, DL1/Ccl19, 
DL4/Ccl19, and DL1/DL4/Ccl19 mice 14 d after immunization (mean ± SD of 4–5 animals per group). (D) Representative FACS profiles of 
CD4+CXCR5+PD1+ TFH cells (top; pregated on CD4+ cells) and GL7+CD95+ GC B cells (bottom; pregated on B220+ cells) from control and DL4/Ccl19  
mice 21 d after immunization with S. mansoni eggs. (E) Bar diagrams represent relative (top) and absolute cell numbers (bottom) of TFH and GC B cells  
in LNs of S. mansoni egg-immunized mice (mean ± SD of 4–5 animals per group). (F) SEA-specific IgG1 antibody levels as measured by ELISA and  
optical diffraction (OD) in the diluted sera of control and DL4/Ccl19 mice at day 21 after immunization with S. mansoni eggs (mean ± SEM of 4–5  
animals per group). *, P < 0.05; **, P < 0.01; ***, P < 0.001. Unpaired Student’s t test was used to determine significance. Results are a composite of two 
independent experiments.
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Figure . DL4 expression on Ccl9-Cre– 
expressing follicular fibroblasts regulates 
Notch-mediated TFH and GC differentiation.  
(A) LN sections of R26-EYFPCcl19 mice 5 d after NP-
CGG immunization stained for EYFP, CD21/35, and 
Pdpn expression. EYFP staining reveals Cre recombi-
nase activity through the deletion of the lox-stop-
lox cassette in the R26 gene locus. Strong CD21/35 
staining in the B zone (BZ) is indicative for activated 
FDCs and weaker staining for B cells, whereas Pdpn 
stains FRCs in the T zone (TZ) and activated FDCs in 
the BZ. White boxes indicate areas of the BZ and TZ, 
respectively, which are also shown in higher magni-
fication on the right side. (B, left) Representative 
FACS profiles of LN stromal cells of DL4/Ccl19  
mice 5 d after NP-CGG immunization, gated on 
AquaCD45Ter119cells, and further classified as 
CD35+Pdpn+CD31 (FDC), CD35PdpnCD31 (DN), 
CD35Pdpn+CD31+ (LEC), or CD35PdpnCD31+ 
(BEC) stromal cells. Percentages indicate the fraction 
present in each quadrant or gate. (right) Represen-
tative histograms showing DL4 surface expression 
on FDCs, FRCs, LECs, and BECs, derived from LNs of 
DL4lox/lox and DL4/Ccl19 mice. Percentages indicate 
the proportion of cells expressing DL4 in DL4lox/lox 
mice (red) versus DL4/Ccl19 mice (blue).  
(C) Representative histograms showing CD157  
(BP-3) and CD21/35 surface expression on FDC 
(CD35+Pdpn+CD31), FRC (CD35Pdpn+CD31), and  
B cells (CD19+TCR). (D) DL4 mRNA expression was 
assessed for stromal cell subsets (sorted as shown  
in B) from 6 LNs per mouse derived from DL4lox/lox and 
DL4/Ccl19 mice (n = 2) 5 d after NP-CGG immuniza-
tion. The numbers indicate the fold enrichment rela-
tive to the mRNA expression level observed for total 
LN from DL4lox/lox mice. (E) PCR for the deleted () 
versus undeleted (loxP) DL4 gene was performed on 
DNA from stromal cell subsets (sorted as shown in B) 
of LNs 5 d after NP-CGG immunization from  
control and DL4/Ccl19 mice. (F) LN sections of  
DL4lox/lox mice 6 d after NP-CGG immunization were 
stained for DL4, CD21/35, and desmin, as indicated. 
Arrows indicate different cell types and sites of DL4 
expression with BZ and TZ shown on the right in 
higher magnification. (G) LN sections of R26-
EYFPCcl19 mice 5 d after NP-CGG immunization 
were stained for DL4, EYFP, and CD21/35, as indi-
cated, with higher magnifications shown on the 
right. (H) LN sections of DL4lox/lox and DL4/Ccl19 
mice 6 d after NP-CGG immunization were stained 
for DL4, CD21/35, and desmin, as indicated. Note 
the loss of DL4 staining in activated CD21/35+  
FDCs of DL4/Ccl19 mice. FDC, follicular DCs; MRCs; 
BRCs; FRC, T zone fibroblastic reticular cells; HEV, 
high endothelial venules. Size bars as indicated. 
Experiments shown are representative of two  
independent experiments and at least two mice  
of each genotype.
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mice and also on the results of BM chimera experiments (Tan 
et al., 2009). This would be consistent with previous studies 
showing that endothelial cells are the source of Notch ligands 
in the developing liver and in the neural stem cell niche (Mc-
Cright et al., 2002; Shen et al., 2004). However, our induc-
ible genetic LOF data for DL1 in BECs argue against the 
vasculature being the essential niche for MZ B cell develop-
ment. In contrast, our results showing that inactivation of 
DL1 in CD31PdpnDL1+ Ccl19-Cre–expressing fibroblasts 
results in a dose dependent and complete loss of MZ B cells 
reveals a novel role for splenic stromal cells in lineage specifi-
cation of immune cells.
Nonhematopoietic stromal elements of SLO were first 
described more than 50 years ago (Glegg et al., 1953). For a 
long time, the primary function of these stromal cells was 
thought to be mainly structural to maintain the primary ar-
chitecture of SLOs (Gretz et al., 1997). Only in recent years 
were stromal cells of SLO phenotypically subdivided into 
multiple subsets fulfilling distinct and important physiological 
functions through their cross talk with immune cells (Mueller 
and Germain, 2009; Turley et al., 2010). One of the major 
features of SLO is the segregation of B cells and T cells in re-
gionally distinct compartments, B cell follicles, and T cell–rich 
zones, which are established by two distinct fibroblast cell 
types and chemokines they produce constitutively. In the 
B cell zone FDCs express the chemokine CXCL13, thereby 
attracting B cells expressing the chemokine receptor CXCR5 
(Gunn et al., 1998a). The T cell zone is organized by FRCs 
expressing the chemokines CCL19 and CCL21 (Luther et al., 
2000; Link et al., 2007) attracting T lymphocytes and DCs 
expressing the chemokine receptor CCR7, thereby allowing 
T cell–DC interactions (Gunn et al., 1998b; Förster et al., 
1999; Gunn et al., 1999). Moreover, T zone FRCs have been 
shown to be an important source of IL-7, which regulates the 
homeostasis of naive T cells within LNs (Link et al., 2007). 
More recently, MRCs were defined as phenotypically distinct 
FRC subset localizing below the marginal sinus in B cell fol-
licles and expressing CXCL13 (Katakai et al., 2008). Interest-
ing new lineage tracing experiments suggest that MRCs are 
the proliferation-competent precursors of FDCs (Jarjour et al., 
2014). The other poorly defined follicular fibroblast type is 
BRCs, which form a network around CD35+ FDCs and have 
been lately proposed as a source of oxysterol chemoattractants 
organizing recently activated B cells in the follicular perime-
ter around FDC-containing GC (Pereira et al., 2009; Yi et al., 
2012; Gatto and Brink, 2013). BRCs are also the likely archi-
tects of conduit microchannels transporting small molecules, 
including antigens and CXCL13, from the marginal sinus to 
FDCs (Heesters et al., 2014). This incomplete list of diverse 
functions of reticular fibroblasts shows that they are directly 
involved in functionally orchestrating immune responses in SLO. 
Our data extend this list by showing that follicular fibroblasts 
also regulate important Notch-mediated differentiation pro-
cesses in spleen and LN.
The current study defines stromal cells (or precursor of these) 
mediating MZ B cell fate specification as CD31PdpnDL1+ 
Within T zones high endothelial venules (HEV) express high 
levels of DL4 as do scattered single cells, with only weak stain-
ing on desmin+ T zone FRC (Fig. 6 F). Therefore, the major-
ity of DL4-expression accessible to TFH cells is found within 
the follicular fibroblasts: FDC, MRC and BRC. Co-staining 
of EYFP and DL4 in activated LN of R26-EYFP Ccl19Cre  
revealed an overlapping expression mainly in FDC, MRC 
and BRC (Fig. 6 G). Importantly, histological staining on ac-
tivated LN of DL4/Ccl19 mice demonstrated a loss of DL4 
expression within MRC and most strikingly within FDC, 
with DL4 expression on HEV and reticular cells within the 
T zone being less affected (Fig. 6 H). Collectively, these results 
strongly suggest that within the LN DL4-expressing FDC, 
MRC and BRC are likely to function as stromal niche cells 
for Notch-mediated TFH differentiation.
DISCUSSION
Although Notch signaling has been implicated in various 
aspects of lymphocyte development and function (Radtke 
et al., 2013) little is known about the essential ligand-expressing 
niche cells in SLO that regulate these processes. Here, we 
present data demonstrating for the first time a functional role 
of fibroblasts in SLO during Notch-mediated lineage speci-
fication and immune responses. Specific DL-expressing 
reticular fibroblasts function as niche cells to promote the de-
velopment of MZ B cells and DCs in the spleen and to regu-
late TFH differentiation in LN and thereby high-affinity 
antibody generation.
Conditional gene targeting experiments of multiple Notch 
components revealed that the specification of the MZ B cell 
fate is strictly dependent on DL1-Notch2 signaling (Saito 
et al., 2003; Hozumi et al., 2004). However, the identity and 
splenic localization of DL1-expressing cells driving MZ 
B cell development remained unknown. Although early stud-
ies revealed expression of DL1 in B cells, B cells and their 
progenitors could be excluded as candidate stimulators of 
Notch signaling because mice with B cell–specific inactiva-
tion of DL1 had normal MZ B cell development (Hozumi 
et al., 2004). This led to the suggestion that spleen cells other 
than B cells, probably DCs, might be the essential niche cells 
for MZ B cell specification. Moreover, this result indicated 
that DL1-mediated Notch signaling must occur between 
Notch2-expressing B cell precursor cells and DL1-expressing 
environmental cells of the spleen rather than between equiva-
lent precursor cells as required for the lateral inhibition model, 
where fluctuations of Notch signaling between equipotent 
progenitor cells control developmental cell fate choices 
(Lewis, 1998).
Although DCs were suggested to be niche cells for MZ 
B cell development, this hypothesis remained to be tested 
in vivo. Our results reveal that mice with DC-specific inac-
tivation of DL1 develop normal numbers of MZ B cells, 
strongly suggesting that DCs do not mediate Notch-induced 
MZ B cell specification. BECs have also been proposed to be 
the ligand-expressing cells that drive MZ B cell development, 
a supposition based on the expression pattern of lacZ knock-in 
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investigated. Alternatively, DCs might receive a DL1 signal 
through their interaction with FRC laying outside of the mar-
ginal sinus, which showed Ccl19-Cre activity but was undetect-
able for DL1 expression by immunohistochemistry. DL1/Ccl19 
mice showed also reductions in CD11b+ and CD8+ DC sub-
sets, which mainly localize to the interfollicular regions and 
the T zone, respectively. Similar observations were obtained 
with DC-specific deletion of RBP/J and Notch-2 (Caton 
et al., 2007; Lewis et al., 2011). It seems plausible that, during 
their maturation, DCs pass DL1-expressing fibroblasts like 
MRCs or BRCs, or see such signals during their residence 
or potential shuttling between the different zones. Again, a 
role for DL1 expression by T zone FRC or other cells cannot 
be formally excluded.
Although MZ B cells and splenic DCs are both depen-
dent on DL1-mediated Notch2 signaling, the threshold or 
sensitivity of Notch signaling for their development or main-
tenance differs. Our data confirm previous observations that 
MZ B cell development is dose-dependent in respect to both 
the ligand (Hozumi et al., 2004) and the receptor (Saito et al., 
2003), suggesting that this process is highly sensitive to small 
changes in receptor or ligand availability. In contrast, the de-
velopment of splenic DCs, including Esam+ DCs, is less sensi-
tive to Notch dosage, as their relative and absolute numbers in 
DL1+/Ccl19 mutant animals was comparable to control ani-
mals. A recent study showed that the development or mainte-
nance of another CD11b+CD103+ DC subset present in the 
lamina propria of the intestine is also dependent on Notch2 
signaling (Lewis et al., 2011; Satpathy et al., 2013). Whether 
this differentiation process is also mediated through the 
interaction of Notch2-expressing DC progenitors and DL1- 
expressing fibroblasts within the lamina propria of the intestine is 
currently unknown and will need further investigation.
In addition to its role in development and possibly lineage 
specification of immune cells, Notch signaling has also been 
implicated in regulating peripheral T and B cell responses, in 
particular through influencing T helper cell functions (Radtke 
et al., 2013). TFH cells constitute a particular subset of CD4+ 
T cells that provide help for B cells to enhance the generation 
of germinal centers and high-affinity antibodies. It is cur-
rently believed that antigen-presenting cells (including DCs 
and antigen-specific B cells) activate, and thereby instruct 
CD4 T cells to differentiate into TFH cells (Crotty, 2011; 
Ramiscal and Vinuesa, 2013). Recently, we reported that T cell–
specific inactivation of both Notch1 and Notch2 results in 
impaired differentiation of TFH cells in draining LNs of mice 
injected with T cell–dependent antigens. In accordance with 
the current view, the absence of functional TFH cells corre-
lated with strongly reduced numbers of GC B cells and high-
affinity antibodies (Auderset et al., 2013). Our BM chimera 
experiments suggest that the cell types mediating Notch- 
induced TFH differentiation are within the radioresistant com-
partment. Consistent with this, deletion of DL ligands using 
Ccl19-Cre indicates that reticular fibroblasts of the B cell folli-
cles are the source of Notch ligands during this process. In this 
case DL4 (as opposed to DL1) is the essential ligand required. 
Ccl19-Cre–expressing reticular cells within splenic B cell fol-
licles. As deletion of DL1 expression was visible in MRCs, 
BRCs, and possibly some FDCs, the critical follicular fibro-
blast type for MZ B cell fate specification requires further 
investigation. These findings raise the question of how MZ 
B cell precursors can receive the essential Notch2 signal if 
mature MZ B cells mostly localize outside of the marginal 
sinus that surrounds DL1-expressing B cell follicles. Interest-
ingly, transfer of MZ B cell precursors in vivo showed that 
they initially localize to the B cell follicle rather than the MZ 
(Chung et al., 2002). These results may indicate that these 
precursors need to transit the follicle to fully mature before 
localizing to the MZ. DL1-expressing follicular fibroblasts 
may therefore be ideally positioned to provide this matura-
tion signal. But how would mature MZ B cells receive the 
Notch2 signal, especially given recent evidence that they 
continuously require Notch2 signals to be retained within the 
MZ (Simonetti et al., 2013)? Another recent study used intra-
vital microscopy to study MZ and follicular B cell migration 
within the spleen of living animals (Arnon et al., 2013). This 
study showed that MZ B cells are very motile and that at least 
20% of all MZ B cells shuttle once per hour between the MZ 
and the follicle. This motility is necessary to rapidly deliver 
antigens from the open blood stream to secluded follicles. 
A possible scenario that reconciles the published studies with 
our data are that MZ B cell progenitors or even mature MZ 
B cells receive the DL1-mediated Notch2 signal from the fol-
licular fibroblasts while they travel from MZs to follicular 
zones and back. Once the Notch signals wears off on the MZ 
B cells, they transiently reposition to the B cell follicle to stay 
alive or maintain their properties, including their MZ resi-
dency. This concept is reminiscent of the one known for naive 
T cells that recirculate constantly between SLO, lymph, and 
blood. Naive T cells need to transit in a regular fashion through 
LN T zones to recognize T zone FRC-derived IL-7 signals to 
stay alive (Link et al., 2007), besides searching for their cog-
nate antigen. If this concept applies also to MZ B cells, then 
the follicular fibroblasts may determine the size of the B cell 
pool found in the neighboring MZ, possibly to keep follicular 
B cells and MZ B cells in reasonable proportions. Constant 
cell migration in and out of niches may be a general principle 
by which the size of a niche-dependent cell population can 
be controlled.
The development of both MZ B cells and splenic 
CD8CD11b+Esam+ DCs is mediated via Notch 2 signaling 
(Saito et al., 2003; Lewis et al., 2011). Because the Esam+ DC 
subset is localized to the same splenic MZ as the MZ B cells 
(Caton et al., 2007), it was speculated that these lineage deci-
sions might be mediated by the same ligand (Radtke et al., 
2013). Indeed, our genetic LOF data obtained via Ccl19- 
Cre–mediated deletion of DL1 confirm this speculation; 
DL1 and not DL4 is the critical ligand for the generation of 
Esam+ DCs. Our data also suggest that the same splenic DL1- 
expressing stromal (precursor) cells might regulate the devel-
opment of these two distinct immune cell types. Whether DCs 
show a similar migration pattern as MZ B cells remains to be 
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cells represents a generic paradigm. This kind of structural or-
ganization allows migrating hematopoietic cells to receive their 
instructive Notch signals within the correct regional com-
partments of primary or SLOs.
MATERIALS AND METHODS
Mice. OTII mice and C57BL/6 CD45.1 (B6.SJL-Ptprca/BoyAiTac) were 
purchased from Charles River and Taconic, respectively. DL1lox/lox, DL4lox/lox, 
J1lox/lox, and J2lox/lox mice (provided by T. Gridley, Center for Molecular Medi-
cine, Maine Medical Center Research Institute, Scarborough, ME) have already 
been described and were crossed to MxCre (Hozumi et al., 2004; Mancini 
et al., 2005; Koch et al., 2008; Xu et al., 2010). DL1lox/lox and DL4lox/lox 
were also bred with Ccl19-Cre (Chai et al., 2013), PDGFi-CreERT 
(T. Petrova, Division of Experimental Oncology 155, CHUV and University 
of Lausanne, Epalinges, Switzerland; M. Fruttiger, The Lowy Medical Research 
Institute, La Jolla, CA; Claxton et al., 2008) and CD11c-Cre (Caton et al., 
2007). Ccl19-Cre mice were crossed to Gt(ROSA)26Sortm1(EYFP)Cos/J 
(R26-EYFP) and Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (mTmG) mice. 
Cre-negative littermates were always used as controls. To inactivate the DL1 
gene using PDGFi-CreERT, control and floxed mutant mice were injected 
i.p. with 1 mg/20 g body weight of tamoxifen (Sigma-Aldrich) for five con-
secutive days. When using the Mx-Cre system, control and floxed mice re-
ceived 5 i.p. injections of 2 µg/g body weight polyI-polyC (Invitrogen) at 2-d 
intervals. All mice on a C57BL/6 background were bred and maintained 
under pathogen-free conditions and. This study has been reviewed and ap-
proved by the Service Vétérinaire Cantonal of Etat de Vaud.
Bone marrow chimeras. BM chimeras were generated using T cell–
depleted BM cells from polyI-polyC control and floxed mice. CD45.1 recipient 
mice were exposed to 2 × 450 rad x-ray-irradiation 24 h before receiving 
0.5–1 × 107 donor BM cells intravenously. Reverse BM chimeras (all on a 
CD45.2 background) were generated by transplanting WT CD45.1 BM cells. 
Radiation chimeras were maintained on antibiotic water (Bactrim®, Roche) for 
1 mo. Peripheral blood lymphocytes were isolated according to standard pro-
tocols 1 mo after transplantation to analyze BM reconstitution. Cells from 
the BM were used to assess the deletion efficiency. Primers for the DL1 dele-
tion PCR were DL1Dfwd 5-CACACCTCCTACTTACCTGA-3 and 
DL1Drev 5-GGCGCTCAAAGGATATGGGA-3. For DL4 deletion, pri-
mers were DL4loxfwd 5-GTGCTGGGACTGTAGCCACT-3 and DL4Drev 
5-CTCGTCTGTTCGCCAAATCTTAC-3.
Immunizations. Mice were either immunized s.c. with 25 µg per site of 
NP35-CGG (Biosearch technologies) in alum (Sigma) or with 5000 S. man-
soni eggs (provided by F. Trottein, Institut Pasteur de Lille, Université Lille 
Nord de France, Lille, France). Draining LNs were isolated 14 and 21 d after 
injection, respectively.
Isolation of cells. Draining axillary, brachial and inguinal LNs were dis-
sected, cut into small pieces and digested for 30 min at 37°C in DMEM 
(GIBCO BRL Life Technologies) containing additional CaCl2 (1.2M), 2% 
(vol/vol) FCS, type IV collagenase (3 µg/ml; Worthington), DNase (40 µg/ml; 
Roche); with shaking and some pipetting. For isolation of spleen stromal 
cells, 1ml of the above digestion mix was injected into spleen before cutting 
it into small pieces and digesting it as LNs. For isolation of splenic DCs, 
spleen was digested in the buffer indicated above but using collagenase D 
(Roche; 1 mg/ml) and digesting for 20 min. After enzymatic digestion, cell 
suspensions were passed through a 40-µm gauze filter and washed with PBS 
containing 5% FCS and 5 mM EDTA (Sigma). To further enrich the splenic 
stromal cell fraction, red blood cells were lysed for 1 min using ammonium 
chloride, and hematopoietic cells depleted using two sequential rounds of 
panning on Ab-coated plates coated with anti-CD45 (clone M1/9.4.3).
Flow cytometry. Non-specific staining was blocked using anti-FcR anti-
bodies (2.4.G2). The following mAbs conjugates were used: CD4 (Clone 
GK1.5), CD8 (YTS109.4), B220 (RA3-6B2), CD21 (ebio8D9), CD23 
The Ccl19cre-expressing cells mediating this process are likely 
to include CD45CD31CD35+Pdpn+DL4+ cells, which phe-
notypically correspond to activated FDCs. Currently, contri-
butions by CD35Pdpn+ MRCs and BRCs cannot be excluded, 
as they show high DL4 protein expression, loss of transcripts 
and protein expression in DL4/Ccl19, and localization in 
areas of TFH cells. Histological evidence suggests a reduction 
in DL4 expression within these two follicular stromal cells, 
but currently there is no well-established flow cytometric 
analysis protocol allowing a more precise analysis at the single-
cell level, including the distinction from T zone FRC that 
may be a DL4 source undetectable by histological methods. 
Our results with the mTmG reporter mice also show Ccl19-
mediated Cre activity in a small fraction of CD45CD31+Pdpn+ 
LEC. However, flow cytometric analysis and mRNA expres-
sion studies of control and DL4/Ccl19 mice did only reveal a 
partial down-regulation of DL4 surface expression in LECs, 
but not in BECs. In conclusion, the most convincing reduc-
tion of DL4 surface expression was observed on activated 
FDCs that co-localize with TFH cells within B cell follicles. 
We therefore favor activated FDCs as being the essential niche 
cells for Notch regulated TFH differentiation.
Although absolute numbers of TFH and GC B cells are 
significantly reduced, some residual cells are still present. The 
reason for the presence of these residual cells is currently un-
known. It is possible that Jagged ligands might compensate 
for the loss of DL4 and/or might contribute to TFH differen-
tiation in LN. Alternatively, this might reflect an incomplete 
inactivation of DL4 in stromal cells of the LN compared with 
the spleen. Another possibility is that Notch does not instruct 
TFH differentiation as it does, for example, during thymic 
T cell lineage specification (Pui et al., 1999; Radtke et al., 
1999), but that Notch rather potentiates TFH cell differentia-
tion through the regulation of its genetic program (Helbig 
et al., 2012). Thus, in the absence of Notch signaling, TFH cells 
would not be completely lost but their numbers would be 
reduced. Such a model was very recently put forward to ex-
plain how Notch signaling can simultaneously regulate Th1, 
Th2, and Th17 responses (Bailis et al., 2013). This model 
unifies contradictory interpretations on the role of Notch sig-
naling in T helper cell differentiation, which were often 
based on a model in which Notch instructs a particular cell 
fate at the expense of other lineages. Our results are indeed 
consistent with a model in which Notch is potentiating or 
reinforcing TFH cell differentiation. The identity of the Notch 
ligands and the ligand-expressing cells that induce the devel-
opment of the other T helper cells (including Th1, Th2, or 
Th17) in vivo is beyond the scope of this manuscript and 
needs to be addressed in future studies.
Overall, our findings demonstrate the important contri-
bution of fibroblastic cells in follicles of both the spleen and 
LN for Notch-mediated differentiation processes and immune 
reactions. These results, together with the observation that 
TECs are the ligand-expressing niche cells for Notch-mediated 
thymopoiesis (Hozumi et al., 2008; Koch et al., 2008), strongly 
suggest that DL expression on stationary microenvironmental 
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Deletion PCR on genomic DNA isolated from stromal subsets. Ge-
nomic DNA was isolated from sorted stromal subsets (FDCs, FRCs, LECs, 
BECs, and DN). PCRs were performed to determine deletion efficiency of 
loxP targeted alleles of DL1 (splenic stromal subsets) or DL4 (LN stromal 
subsets). The deleted and undeleted lox alleles were detected separately by 
PCR using specific primers.
DL1 deletion PCR primer sequences were as follows: DL1lox_sense, 
5-CACACCTCCTACTTACCTGA-3; DL1lox_as, 5-GAGAGTACT-
GGATGGAGCAAG-3; DL13’lox Del, 5-GGCGCTCAAAGGATAT-
GGGA-3. The triple PCR will amplify a 238-bp fragment of the floxed 
allele and a 337-bp deletion fragment.
DL4 deletion PCR primer sequences were as follows: DL4lox_sense, 
5-GTGCTGGGACTGTAGCCACT-3; DL4lox_as, 5-TGTTAGGGA-
TGTCGCTCTCC-3; DL43’lox Del, 5-CTCGTCTGTTCGCCAAATC-
TTAC-3. The triple PCR will amplify a 490-bp fragment of the floxed 
allele and a 950-bp deletion fragment.
T cell proliferation assay. Splenic and LN CD4+ T cells from OVA-spe-
cific OT-II transgenic mice were enriched using MACS beads. After stain-
ing with 5 µM CFSE, cells were injected i.v. (1–3 × 106 per animal) into 
DL1lox/lox Ccl19-Cre or control mice. After 24 h, recipient mice received 
100 µg OVA and 75 µg LPS i.v. (both from Sigma-Aldrich) and were ana-
lyzed 3 or 5 d later.
Statistical analysis. Bar diagrams were compiled using Graph Pad Prism or 
Excel statistical analysis software. For comparison of pooled data between 
two different groups, unpaired Student’s t tests were used to determine sig-
nificance. *, P < 0.05; **, P < 0.01.
Ethics statement. All animal work was conducted according to Swiss na-
tional guidelines. All mice were kept in the animal facility under EPFL or 
UNIL animal care regulations. They were housed in individual cages at 
23 ± 1°C with a 12-h light/dark cycle. All animals were supplied with food 
and water ad libitum. This study has been reviewed and approved by the 
Service Vétérinaire Cantonal of Etat de Vaud.
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